February 3, 2025

FDA approves first non-opioid pain medicine in more than 20 years

January 31, 2025

The drug, Journavx (suzetrigine), inhibits an ion channel in peripheral nerves…

The drug, Journavx (suzetrigine), inhibits an ion channel in peripheral nerves…
Read More

About Author

Beth Mole

See author's posts

More Stories

Computer model simplifies immune cell identification for lung cancer treatment

February 3, 2025

Ugandan health authorities are set to begin an Ebola vaccine trial after new outbreak kills a nurse

February 3, 2025

Canadian study reveals alcohol-related deaths up 18% during pandemic

February 2, 2025

You may have missed

Aplagon secures EUR 7 million for APAC phase 2a trials

Aplagon secures EUR 7 million for APAC phase 2a trials

February 3, 2025
CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients

CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients

February 3, 2025
Computer model simplifies immune cell identification for lung cancer treatment

Computer model simplifies immune cell identification for lung cancer treatment

February 3, 2025
Ugandan health authorities are set to begin an Ebola vaccine trial after new outbreak kills a nurse

Ugandan health authorities are set to begin an Ebola vaccine trial after new outbreak kills a nurse

February 3, 2025
Canadian study reveals alcohol-related deaths up 18% during pandemic

Canadian study reveals alcohol-related deaths up 18% during pandemic

February 2, 2025